-
CompareTheraPEAK® ProFreeze® Freezing Medium, Chemically Defined, 100ml (2x)Catalog #: BEBP12-769E
TheraPEAK® ProFreeze® Freezing Medium, chemically defined, non-animal origin, 100 mL (2x)
Sales unit: each -
CompareX-VIVO® 15 Serum-free Hematopoietic Cell MediumCatalog #: 02-053Q
X-VIVO® 15, with L-Glutamine, gentamicin, recombinant transferrin, and phenol red, xenofree, 1 L
Sales unit: each -
CompareX-VIVO® 15 Serum-free Hematopoietic Cell MediumCatalog #: 02-060F
X-VIVO® 15, Serum-free hematopoietic cell medium, with L-Glutamine, gentamicin and phenol red, xenofree, 500mL
Sales unit: each -
CompareLV Nucleocuvette® Cartridge PRO, weldable (1 pc)Catalog #: V4LN-8020W
Flow-through reaction vessel for the 4D-Nucleofector® LV Unit PRO for research and process development. Easily scalable to up to 1 billion cells. Use in combination with P3 Nucleofector® Solution LV Sets and 4D-Nucleofector® LV Reservoirs.
Sales unit: each -
CompareHanks' Buffered Saline Solution, HBSS without calcium and magnesium, with phenol redCatalog #: 10-543F
Hanks' BSS (1X), HBSS without calcium and magnesium, with phenol red, 500mL.
Please note: this product is no longer available in Europe and Africa.
For customers in the Americas and Asia-Pacific regions, the product will be discontinued by June 30, 2022. It will be sold until stock is depleted.
Sales unit: Bottle -
CompareTheraPEAK® LV Nucleocuvette® Cartridge, weldable (5 pcs)Catalog #: G4LN-7520W
For use in combination with TheraPEAK® Nucleofector® Solution Sets, supporting the use of the 4D-Nucleofector® LV Unit in a GMP environment.
Sales unit: items -
CompareLatitude® Midigel TBE, 1%Catalog #: 57220
Latitude® Midigel (10 × 15 cm) 1%, 20-well, 8 gels
Sales unit: each -
Compare
Latitude® Midigel, 2%
Catalog #: 57239Latitude® Midigel Gels TBE (10 × 15 cm), 2% SeaKem® LE Agarose, 15-well, prestained with Ethidium Bromide, 8 gels
Sales unit: each -
CompareLatitude® Midigel TBE, 1%Catalog #: 57230
Latitude® Midigel (10 × 15 cm) 1%, 2 × 20-well, 8 gels
Sales unit: each -
Compare
Latitude® Midigel TBE, 2%
Catalog #: 57231Latitude® Midigel (10 × 15 cm) 2%, 2 × 20-well, 8 gels
Sales unit: each
-
Instructions - QCL-1000™ Assay (English)Detailed instructions for performing the QCL-1000™ Endpoint Chromogenic LAL Assay
-
PYROSTAR™ ES-F Series BrochureThe PYROSTAR™ ES-F series of reagents are endotoxin-specific and unreactive to β-D-Glucan
-
QCL-1000™ Endpoint Chromogenic LAL Assay - Technical TipsThe Importance of Glass Tubes /The Problem with PlasticIncubation Method96-well Plates1 EU/ml Standard PreparationVortexing and Mixing Potential Endotoxin Contaminants
-
Instructions – Water for Cell CultureData sheet WFI
-
Troubleshooting Guide - Testing Oil Solutions with PYROGENT™ Gel Clot LAL AssayEndotoxins, due to their lipid character, tend to remain associated with oils and do not readily enter the aqueous phase of water-oil mixtures. This Tech Tip describes the use of a dispersing agent, PYROSPERSE™, to allow for dissociation of the endotoxin from the oils and for subsequent detection of endotoxin in the aqueous phase by the PYROGENT™ Gel Clot LAL Assay.
-
Troubleshooting Guide - Endpoint Chromogenic LAL Assay Procedure (English)This is a step-by-step guide depicting how to perform the endpoint chromogenic LAL assay in a 96-well plate.
-
Instructions - MycoZap™ Mycoplasma Elimination ReagentMycoZap™ Mycoplasma Elimination Reagent Instructions
-
Endpoint Chromogenic Limulus Amebocyte Lysate (LAL) Assay Procedure Quick GuideThis is a step-by-step guide depicting how to perform the endpoint chromogenic LAL assay in a 96-well plate. (English)
-
Overcoming Assay Inhibition or Enhancement Technical TipsOne of the most time-consuming aspects of endotoxin testing using Limulus Amebocyte Lysate (LAL) is pretreating samples to overcome assay inhibition and enhancement. All assays, independent of methodology, are standardized using endotoxin in water. Lonza offers three solutions for overcoming LAL testing inhibitions
-
White-Paper LAL-vs-rFCLonza discusses the transistion From LAL to rFC Assays